MedlinePlus health topic page for patients on safe opioid use, including questions to ask and information to share with your health care provider when considering a prescription opioid for treatment of pain from an injury or surgery, pain due to a severe health condition, or chronic pain.
The US Centers for Disease Control and Prevention (CDC) recommendations for primary care clinicians who are prescribing opioids for adult patients with acute, subacute, or chronic pain outside of active cancer or sickle cell disease treatment, palliative care, and end-of-life care.
International guidelines for general practitioners on opioid analgesic deprescribing in adults. Recommendations include implementing a deprescribing plan when opioids are first prescribed and gradual and individualized deprescribing, with regular monitoring and review. Deprescribing may not be appropriate for every patient.
The CDC has a mobile application available for iOS (Apple) and Android devices. This app collects the newest CDC-approved guidelines, tools, calculators, and resources for prescribing opioids.
The National Institute on Drug Abuse (NIDA) Clinical Trials Network has a scientifically validated online screening tool designed to assess a patient’s risk for substance misuse and substance use disorder in the setting of pain management, and to assist the health care provider with prevention and treatment strategies.
NIDA resource including treatment information, case study videos, discharge instructions, tools and assessments (clinical opioid withdrawal scale and questions for emergency clinicians to ask to help with identification of an opioid use disorder), provider resources, and FAQs.
A prescription drug monitoring program (PDMP) is an electronic database that tracks controlled substance prescriptions. PDMPs can help identify patients who may be misusing prescription opioids or other prescription drugs and who may be at risk for overdose.
The American College of Obstetricians and Gynecologists (ACOG) recommendations for treating women with substance use disorder in pregnancy.
An initiative of the US Department of Health and Human Services (HHS) Office on Women’s Health (OWH) that examines prevention, treatment, and recovery issues for women who misuse opioids, have opioid use disorders, and/or overdose on opioids.